The YAP1 and EPHA3 receptor tyrosine kinase axis regulates cellular plasticity and treatment response
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2026.112368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Marwah M Al-Mathkour und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Center for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, GA, United States of Am…. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Transcription Factors, Prostatic Neoplasms, Receptor, EphA3. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMHD NIH HHS, National Institute on Minority Health and Health Disparities, Division of Molecular and Cellular Biosciences.
Abstract (Originalsprache)
The transcriptional coregulator YAP1 and the receptor tyrosine kinase EPHA3 regulate key cellular processes, including cell interactions, motility, survival, tissue development, carcinogenesis, and metastasis. Although their individual roles have been extensively studied, their cooperative functions remain poorly understood. Here, we investigated the relationship between EPHA3 and YAP1 in human prostate tumor tissues and cell models. Integrated transcriptomic and immunological analyses reveal a strong positive correlation between YAP1 and EPHA3 expression, which is significantly associated with tumor progression. EPHA3 knockout reduces cell proliferation and increases sensitivity to the androgen receptor inhibitor enzalutamide and the YAP1-TEAD inhibitor CA3 in vitro. EPHA3 depletion also reduces GTP-bound active RHOA and phosphorylated ERK levels and differentially affects epithelial-mesenchymal transition and cancer stem cell programs. In addition, EPHA3 silencing attenuates cell migration and invasion, an effect dependent on YAP1 activation. Bioinformatics analysis further indicates that high YAP1 and EPHA3 correlate with developmental and EMT-related gene signatures. These results demonstrate that the YAP1-EPHA3 axis is a key mediator of cell survival, plasticity, and tumor progression, and may serve as a promising cancer drug target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Center for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, GA, United States of America; Miller School of Medicine, University of Miami, Miami, FL, Unit…
- Department of Biological Sciences, Center for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, GA, United States of America; Morehouse School of Medicine, Atlanta, GA, United States of Ame…
- Department of Biological Sciences, Center for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, GA, United States of America.
- Department of Biological Sciences, Center for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, GA, United States of America; Winship Cancer Institute, Emory University, Atlanta, GA, United…
Förderung
- NIMHD NIH HHS
- National Institute on Minority Health and Health Disparities
- Division of Molecular and Cellular Biosciences
- National Institutes of Health
- Augusta University
Zitieren
APA
Al-Mathkour, M. M., Dwead, A. M., Khazaw, K., & Cinar, B. (2026). The YAP1 and EPHA3 receptor tyrosine kinase axis regulates cellular plasticity and treatment response. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112368
Vancouver
Al-Mathkour MM, Dwead AM, Khazaw K, Cinar B. The YAP1 and EPHA3 receptor tyrosine kinase axis regulates cellular plasticity and treatment response. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112368
BibTeX
@article{AlMathkour2026,
author = {Al-Mathkour, Marwah M and Dwead, Abdulrahman M and Khazaw, Kezhan and Cinar, Bekir},
title = {The YAP1 and EPHA3 receptor tyrosine kinase axis regulates cellular plasticity and treatment response},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2026.112368}
}
EUVIMED